Faculty Affiliates

Alan Budney, PhD

Professor, Geisel School of Medicine at Dartmouth

Cannabis Use, Measurement, Consequences, Risks, Benefits; Clinical Application of Contingency Management; Digital Interventions for Reduction in Substance Use; Leveraging Social Media to Enhance Research on Substance Use


Alan Budney, PhD
Professor, Geisel School of Medicine at Dartmouth

46 Centerra Parkway, Suite 315 Lebanon, NH 03766



Selected Publications
  • Budney AJ, Borodovsky JT, Struble CA, Habib MI, Shmulewitz D, Livne O, Aharonovich E, Walsh C, Cuttler C, Hasin DS. Estimating THC consumption from smoked and vaped cannabis products in an online survey of adults who use cannabis. Cannabis Cannabinoid Res. 2024 Apr;9(2):688-698. doi: 10.1089/can.2022.0238. PMID: 36521175; PMCID: PMC10998014.
  • Borodovsky JT, Hasin DS, Shmulewitz D, Walsh C, Livne O, Aharonovich E, Struble CA, Habib MI, Budney AJ. Typical hits, grams, or joints: Evaluating cannabis survey measurement strategies for quantifying consumption. Cannabis Cannabinoid Res. 2024 Apr;9(2):646-658. doi: 10.1089/can.2022.0237. PMID: 36577020; PMCID: PMC10998027.
  • Shmulewitz D, Budney AJ, Borodovsky JT, Bujno JM, Walsh CA, Struble CA, Livne O, Habib MI, Aharonovich E, Hasin DS. Dimensionality and differential functioning of DSM-5 cannabis use disorder criteria in an online sample of adults with frequent cannabis use. J Psychiatr Res. 2023 Jul;163:211-221. doi: 10.1016/j.jpsychires.2023.05.048. PMID: 37224773.
  • Hasin DS, Borodovsky J, Shmulewitz D, Walsh C, Struble CA, Livne O, Habib MI, Fink DS, Aharonovich E, Budney A. Adult use of highly-potent Δ9-THC cannabis concentrate products by U.S. state cannabis legalization status, 2021. Addict Behav. 2023 May;140:107617. doi: 10.1016/j.addbeh.2023.107617. PMID: 36736229; PMCID: PMC9930475.
  • Walsh CA, Struble CA, Aharonovich E, Shmulewitz D, Borodovsky J, Habib MI, Budney A, Livne O, Hasin DS. Evaluating cannabis exposure in survey items: Insights, strategies, and remaining challenges identified from cognitive interviewing. Drug Alcohol Depend Rep. 2023 Apr 19;7:100161. doi: 10.1016/j.dadr.2023.100161. PMID: 37179574; PMCID: PMC10173391.
  • Tackett AP, Wong M, Cho J, Harlow AF, Vogel EA, Han DH, Barrington-Trimis JL, McConnell R, Budney AJ, Audrain-McGovern JE, Lerman C, Monterosso J, Leventhal AM. Willingness to use commercial nicotine gums, lozenges, and gummies among nontobacco using adolescents in Southern California. J Adolesc Health. 2023 Feb;72(2):277-286. doi: 10.1016/j.jadohealth.2022.09.027. PMID: 36470691.
  • Fontana TJK, Schulz JA, Budney AJ, Villanti AC. Feasibility and utility of a structured guide for cannabis tolerance breaks in young adults. J Am Coll Health. 2023 Jan 3:1-5. doi: 10.1080/07448481.2022.2155061. Epub ahead of print. PMID: 36595624.
  • Anderson MA, Budney AJ, Jacobson NC, Nahum-Shani I, Stanger C. End user participation in the development of an ecological momentary intervention to improve coping with cannabis cravings: Formative study. JMIR Form Res. 2022 Dec 15;6(12):e40139. doi: 10.2196/40139. PMID: 36520509.
  • Struble CA, Borodovsky JT, Habib MI, Hasin DS, Shmulewitz D, Livne O, Walsh C, Aharonovich E, Budney AJ. Cannabis practices among a gender-diverse sample of young adults. Drug Alcohol Depend Rep. 2022 Dec;5:100113. doi: 10.1016/j.dadr.2022.100113. PMID: 36741544; PMCID: PMC9894216.
  • Sofis MJ, Lemley SM, Jacobson NC, Budney AJ. Initial evaluation of domain-specific episodic future thinking on delay discounting and cannabis use. Exp Clin Psychopharmacol. 2022 Dec;30(6):918-927. doi: 10.1037/pha0000501. PMID: 34096759; PMCID: PMC9214768.
  • Goodwin RD, Shevorykin A, Carl E, Budney AJ, Rivard C, Wu M, McClure EA, Hyland A, Sheffer CE. Daily cannabis use is a barrier to tobacco cessation among tobacco Quitline callers at 7-month follow-up. Nicotine Tob Res. 2022 Oct 17;24(10):1684-1688. doi: 10.1093/ntr/ntac096. PMID: 35417562.
  • Livne O, Budney A, Borodovsky J, Walsh C, Shmulewitz D, Fink DS, Struble CA, Habib M, Aharonovich E, Hasin DS. Delta-8 THC use in US adults: Sociodemographic characteristics and correlates. Addict Behav. 2022 Oct;133:107374. doi: 10.1016/j.addbeh.2022.107374. PMID: 35644057; PMCID: PMC9245337.
  • Keller OC, Budney AJ, Struble CA, Teepe GW. Blending digital therapeutics within the healthcare system. In Jacobson N, Kowatsch T, Marsch LA, editors. Digital therapeutics for mental health and addiction: The state of the science and vision for the future. Academic Press; 2022 September 27. Chapter 5. Paperback ISBN: 9780323900454.  
  • Sherman BJ, Sofis MJ, Borodovsky JT, Gray KM, McRae-Clark AL, Budney AJ. Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder. Psychol Addict Behav. 2022 Aug;36(5):505-514. doi: 10.1037/adb0000760. PMID: 34197135; PMCID: PMC8720114.
  • Borodovsky JT, Sofis MJ, Sherman BJ, Gray KM, Budney AJ. Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints. Psychol Addict Behav. 2022 Aug;36(5):515-525. doi: 10.1037/adb0000817. PMID: 35084903; PMCID: PMC9325921.